CRY2 and Impaired glucose tolerance: Studies have found that mice carrying null mutations in cryptochrome circadian regulator 2 (Cry2) gene have a number of metabolic abnormalities, including increased insulin sensitivity, impaired glucose tolerance, reduced adipose tissue and body weight, and abnormal circadian rhythmicity.